Acurx Pharmaceuticals (ACXP) Market Capitalization (2021 - 2026)

Acurx Pharmaceuticals (ACXP) has reported Market Capitalization for 6 consecutive years, with $7.3 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Market Capitalization fell 40.3% year-over-year to $7.3 million; the trailing twelve-month figure through Jun 2026 stood at $7.3 million (down 40.3% YoY), and the FY2025 full-year result was $3.7 million, down 73.08% from the prior year.
• Market Capitalization slipped to $7.3 million in Q2 2026 per ACXP's latest filing, from $10.1 million in the prior quarter.
• Across five years, Market Capitalization topped out at $55.4 million in Q4 2023 and bottomed at $3.7 million in Q4 2025.
• Historically, Market Capitalization has averaged $26.3 million across 5 years, with a median of $32.8 million in 2022.
• The sharpest annual moves came in 2024 and 2025: Market Capitalization surged 63.34% in 2024, then slumped 77.37% in 2025.
• Over 5 years, Market Capitalization stood at $46.3 million in 2022, then rose by 19.74% to $55.4 million in 2023, then sank by 74.98% to $13.9 million in 2024, then slumped by 73.08% to $3.7 million in 2025, then surged by 94.51% to $7.3 million in 2026.
• According to Business Quant data, Market Capitalization over the past three periods registered $7.3 million, $10.1 million, and $3.7 million for Q2 2026, Q1 2026, and Q4 2025 respectively.